Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast on May 2, 2024 In the wake of recent bipartisan policy wins in…
As we mark Earth Day, we have just experienced the hottest March on record. But…
What happens when music therapists and neuroscientists team up? Patients win, says Dr. Francis Collins.…
Originally published April 9, 2024 She’s received worldwide praise for singing at the Super Bowl,…
Originally published April 4, 2024 It’s about seven months to election day and our regular…
Originally published March 28, 2024 Medicare just announced that it will pay for weight loss…